Epigenetic regulators, such as DNA methylation and histone modification, control gene expression without altering the DNA sequence. Abnormal epigenetic modifications can lead to cancer by silencing tumor suppressor genes or activating oncogenes. Drugs targeting these modifications, like histone deacetylase inhibitors and DNA methyltransferase inhibitors, are being developed for cancer treatment.
